Literature DB >> 12653853

CTLA-4 (CD152) expression in peripheral blood T cells in Kawasaki disease.

T Matsubara1, R Anwar, M Fujiwara, T Ichiyama, S Furukawa.   

Abstract

Kawasaki disease (KD) is an acute febrile illness of early childhood caused by vasculitis. Whether or not peripheral blood T cells are activated in acute KD remains uncertain, as some reports have presented evidence of peripheral blood T cell activation, whereas others suggest that the level of peripheral blood T cell activation is low during acute KD. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4, CD152) is a surface molecule of activated T cells. We therefore investigated intracellular CTLA-4 expression in the peripheral blood T cells of patients with acute KD as a marker of T cell activation. We collected blood samples from 20 patients with KD and six with Epstein-Barr virus infectious mononucleosis (EBV-IM) who were admitted to our hospital, as well as 13 healthy children. We determined the intracellular expression of CTLA-4 in T cells by flow cytometry. We demonstrated that the intracellular expression of CTLA-4 is up-regulated in peripheral blood CD3+ T cells, CD4+ T cells and CD8+ T cells at the early part of the acute stage in KD. However, the mean percentages of intracellular T cells expressing CTLA-4 in EBV-IM patients were about fourfold higher than those in T cells from patients with acute KD. Our results suggested that the level of activation of peripheral blood T cells is very low during acute KD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12653853      PMCID: PMC1808675          DOI: 10.1046/j.1365-2249.2003.02109.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Serum soluble CD4 and CD8 levels in Kawasaki disease.

Authors:  S Furukawa; T Matsubara; K Tsuji; T Motohashi; K Okumura; K Yabuta
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

2.  Abnormalities of immunoregulation in Kawasaki syndrome.

Authors:  K Barron; C DeCunto; J Montalvo; F Orson; D Lewis
Journal:  J Rheumatol       Date:  1988-08       Impact factor: 4.666

3.  Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome.

Authors:  D Y Leung; E T Chu; N Wood; S Grady; R Meade; R S Geha
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

4.  A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan.

Authors:  T Kawasaki; F Kosaki; S Okawa; I Shigematsu; H Yanagawa
Journal:  Pediatrics       Date:  1974-09       Impact factor: 7.124

5.  Regulation of surface and intracellular expression of CTLA-4 on human peripheral T cells.

Authors:  X B Wang; C Y Zheng; R Giscombe; A K Lefvert
Journal:  Scand J Immunol       Date:  2001-11       Impact factor: 3.487

6.  CD4 alphabeta T lymphocytes express high levels of the T lymphocyte antigen CTLA-4 (CD152) in acute malaria.

Authors:  T Schlotmann; I Waase; C Jülch; U Klauenberg; B Müller-Myhsok; M Dietrich; B Fleischer; B M Bröker
Journal:  J Infect Dis       Date:  2000-06-30       Impact factor: 5.226

Review 7.  CD28/CTLA-4 and CD80/CD86 families: signaling and function.

Authors:  J M Slavik; J E Hutchcroft; B E Bierer
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

8.  Imbalance among T-cell subsets in patients with coronary arterial aneurysms in Kawasaki disease.

Authors:  M Terai; Y Kohno; K Niwa; T Toba; N Sakurai; H Nakajima
Journal:  Am J Cardiol       Date:  1987-09-01       Impact factor: 2.778

9.  Mononuclear cell subsets and coronary artery lesions in Kawasaki disease.

Authors:  S Furukawa; T Matsubara; K Yabuta
Journal:  Arch Dis Child       Date:  1992-06       Impact factor: 3.791

10.  Class II major histocompatibility antigen expression on coronary arterial endothelium in a patient with Kawasaki disease.

Authors:  M Terai; Y Kohno; M Namba; T Umemiya; K Niwa; H Nakajima; A Mikata
Journal:  Hum Pathol       Date:  1990-02       Impact factor: 3.466

View more
  6 in total

1.  Th1 and Th2 cytokine production is suppressed at the level of transcriptional regulation in Kawasaki disease.

Authors:  J Kimura; H Takada; A Nomura; T Ohno; Y Mizuno; M Saito; K Kusuhara; T Hara
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

Review 2.  Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease.

Authors:  T Matsubara; T Ichiyama; S Furukawa
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

3.  CTLA-4, position 49 A/G polymorphism associated with coronary artery lesions in Kawasaki disease.

Authors:  Ho-Chang Kuo; Chi-Di Liang; Hong-Ren Yu; Chih-Lu Wang; I-Chun Lin; Chieh-An Liu; Jen-Chieh Chang; Chiu-Ping Lee; Wei-Chiao Chang; Kuender D Yang
Journal:  J Clin Immunol       Date:  2010-11-17       Impact factor: 8.317

4.  Expression of CTLA-4 (CD152) in peripheral blood T cells of children with influenza virus infection including encephalopathy in comparison with respiratory syncytial virus infection.

Authors:  H Ayukawa; T Matsubara; M Kaneko; M Hasegawa; T Ichiyama; S Furukawa
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

5.  A Clinical and Laboratory Approach to the Evaluation of Innate Immunity in Pediatric CVID Patients.

Authors:  Necil Kutukculer; Elif Azarsiz; Neslihan Edeer Karaca; Ezgi Ulusoy; Guldane Koturoglu; Guzide Aksu
Journal:  Front Immunol       Date:  2015-04-27       Impact factor: 7.561

6.  Intravenous Immunoglobulin Therapy Restores the Quantity and Phenotype of Circulating Dendritic Cells and CD4+ T Cells in Children With Acute Kawasaki Disease.

Authors:  Nana Wang; Zhongyue Chen; Fan Zhang; Qianwen Zhang; Ling Sun; Haitao Lv; Bo Wang; Jie Shen; Xufang Zhou; Feiyan Chen; Binwei Zhang; Lijun Meng; Huiting Zhou; ZhenJiang Bai; Jie Huang
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.